Stifel Nicolaus Increases Intuitive Surgical (NASDAQ:ISRG) Price Target to $430.00

Intuitive Surgical (NASDAQ:ISRG) had its target price boosted by equities research analysts at Stifel Nicolaus from $420.00 to $430.00 in a report released on Monday, Benzinga reports. The brokerage presently has a “buy” rating on the medical equipment provider’s stock. Stifel Nicolaus’ price objective indicates a potential upside of 9.99% from the company’s current price.

ISRG has been the subject of a number of other research reports. Barclays increased their price target on Intuitive Surgical from $385.00 to $430.00 and gave the stock an “overweight” rating in a research note on Thursday, January 25th. StockNews.com lowered Intuitive Surgical from a “buy” rating to a “hold” rating in a research note on Thursday, February 29th. Truist Financial raised their price objective on Intuitive Surgical from $390.00 to $435.00 and gave the company a “buy” rating in a research report on Wednesday, January 24th. Wells Fargo & Company raised their price objective on Intuitive Surgical from $363.00 to $416.00 and gave the company an “overweight” rating in a research report on Friday, January 19th. Finally, Piper Sandler raised their price objective on Intuitive Surgical from $325.00 to $425.00 and gave the company an “overweight” rating in a research report on Wednesday, January 24th. Five research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $375.70.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $390.96 on Monday. The firm has a market capitalization of $138.58 billion, a price-to-earnings ratio of 77.73, a price-to-earnings-growth ratio of 6.03 and a beta of 1.36. Intuitive Surgical has a one year low of $252.04 and a one year high of $403.76. The business has a fifty day moving average price of $387.86 and a 200-day moving average price of $338.94.

Intuitive Surgical (NASDAQ:ISRG) last posted its quarterly earnings data on Tuesday, January 23rd. The medical equipment provider reported $1.60 EPS for the quarter, topping the consensus estimate of $1.48 by $0.12. Intuitive Surgical had a return on equity of 13.11% and a net margin of 25.24%. The firm had revenue of $1.93 billion during the quarter, compared to analyst estimates of $1.89 billion. During the same period in the prior year, the business posted $0.91 EPS. Intuitive Surgical’s revenue was up 16.6% on a year-over-year basis. On average, equities research analysts expect that Intuitive Surgical will post 4.93 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other news, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the completion of the sale, the senior vice president now owns 1,842 shares of the company’s stock, valued at $736,800. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other news, Director Alan J. Levy sold 2,000 shares of Intuitive Surgical stock in a transaction that occurred on Friday, January 26th. The shares were sold at an average price of $370.20, for a total transaction of $740,400.00. Following the completion of the sale, the director now owns 25,319 shares of the company’s stock, valued at $9,373,093.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Mark Brosius sold 196 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, March 5th. The shares were sold at an average price of $400.00, for a total transaction of $78,400.00. Following the sale, the senior vice president now directly owns 1,842 shares of the company’s stock, valued at approximately $736,800. The disclosure for this sale can be found here. Insiders sold a total of 248,418 shares of company stock valued at $95,927,097 over the last 90 days. Insiders own 0.80% of the company’s stock.

Hedge Funds Weigh In On Intuitive Surgical

Large investors have recently bought and sold shares of the business. OFI Invest Asset Management bought a new position in Intuitive Surgical in the third quarter worth approximately $25,000. Baystate Wealth Management LLC raised its stake in Intuitive Surgical by 150.0% in the fourth quarter. Baystate Wealth Management LLC now owns 75 shares of the medical equipment provider’s stock worth $25,000 after buying an additional 45 shares in the last quarter. MCF Advisors LLC raised its stake in Intuitive Surgical by 108.1% in the fourth quarter. MCF Advisors LLC now owns 77 shares of the medical equipment provider’s stock worth $26,000 after buying an additional 40 shares in the last quarter. Headinvest LLC bought a new position in Intuitive Surgical in the third quarter worth approximately $28,000. Finally, Able Wealth Management LLC bought a new position in Intuitive Surgical in the fourth quarter worth approximately $28,000. Institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.